Recruiting NA Neck Pain

Tests treatment safety and results for Neck Pain

Official title Effectiveness of PRP Pharmacopuncture for Chronic Neck Pain in Cervical Myofascial Syndrome of the Upper Trapezius

ClinicalTrials.gov ID: NCT07119255

What this study is testing

What it's testing
The goal of this clinical trial is to learn whether pharmacopuncture with Platelet-Rich Plasma (PRP) is effective for treating chronic neck pain in cervical myofascial syndrome related to the upper trapezius muscle. The main questions it aims to answer are: 1.
  • You might receive a placebo (an inactive treatment) instead of the study drug.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 59

You may be able to join if

  • Male or female, aged 18 to 59 years.
  • Experiencing neck pain for more than 3 months (chronic).
  • Neck pain classified as Grade I to III according to the Neck Pain Task Force classification.
  • Presence of referred pain pattern on physical examination consistent with the distribution of the upper trapezius muscle.
  • Visual Analogue Scale (VAS) score between 30 and 70 mm (out of 100 mm) during activity (e.g., daily activities or light exercise).

You likely can't join if

  • Hemoglobin level \<13 g/dL for males or \<12 g/dL for females.
  • Platelet count \<150,000/μL.
  • Presence of fever (≥37.5°C).
  • Diagnosis of fibromyalgia.
  • Structural abnormalities of the cervical spine other than degenerative changes, such as fractures, cervical spine injuries, space-occupying lesions...
  • History of cervical spine surgery.
See the full eligibility criteria
Who can join
  • Male or female, aged 18 to 59 years.
  • Experiencing neck pain for more than 3 months (chronic).
  • Neck pain classified as Grade I to III according to the Neck Pain Task Force classification.
  • Presence of referred pain pattern on physical examination consistent with the distribution of the upper trapezius muscle.
  • Visual Analogue Scale (VAS) score between 30 and 70 mm (out of 100 mm) during activity (e.g., daily activities or light exercise).
  • Willing to participate in the study until completion and has signed the informed consent form.
What rules you out
  • Hemoglobin level \<13 g/dL for males or \<12 g/dL for females.
  • Platelet count \<150,000/μL.
  • Presence of fever (≥37.5°C).
  • Diagnosis of fibromyalgia.
  • Structural abnormalities of the cervical spine other than degenerative changes, such as fractures, cervical spine injuries, space-occupying lesions (SOL), infections, neoplasms, or systemic diseases confirmed by...
  • History of cervical spine surgery.
  • Presence of tumors, wounds, or skin infections at the needle insertion site.
  • Diagnosed with blood disorders or currently taking anticoagulant or antiplatelet medications.
  • History of hypersensitivity reactions to acupuncture (e.g., metal allergy, severe atopy, keloids, or other skin hypersensitivities).
  • Uncontrolled cardiovascular disease or diabetes mellitus.
  • History of pharmacopuncture therapy to the upper trapezius muscle within the past 6 months.
  • Use of anti-inflammatory medication within the past 2 weeks.
  • Currently pregnant or breastfeeding.

The study team makes the final eligibility decision.

Where it's taking place

  • Jakarta, Indonesia

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years to 59 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Jakarta, Indonesia. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.